Immunotherapy has garnered national attention recently by being showcased on the front cover of Time magazine. Immunotherapy has been an emerging and exciting therapeutic area that has experienced massive growth in terms of research and development expenditures and the sheer number of clinical trials. Immunotherapy ushers in a new class of potentially promising therapies by harnessing the body’s immune system to recognize and eradicate debilitating diseases, specifically cancer and chronic viral infections. This immunotherapy approach may inevitably result in a paradigm shift from traditional medical intervention. Immunotherapy possesses holistic attributes by harnessing the body’s immune system to contend with or in some cases prevent disease. In addition to the holistic aspects, immunotherapy has been shown to have a favorable side effect profile and best-in-class efficacy across many different disease states. These therapies may provide powerful technology to contend with a host of diseases, and in a future state, may potentially serve as a preventative technology similar to a traditional vaccine. Immunotherapy has evolved into many different classifications with differing modalities over the past few years, which has given rise to a growing number small-cap biotechnology companies with potential investment opportunities via an immunotherapy ETF. In late 2015, Loncar Cancer Immunotherapy ETF launched (NASDAQ:CNCR) and provides investors with an opportunity to invest in this unique cohort. Continue reading "TIME Magazine Showcases Immunotherapy – Immunotherapy ETF Now Trading"→
Hello traders and MarketClub members everywhere, Happy Monday. It's a very happy Monday morning for Bill Ackman who owns 32% of Allergan's stock. I would also like to point out that it is a happy Monday for many MarketClub members who read on our blog over two months ago about this stock. I also did a special update on Allergan Inc. (NYSE:AGN) on October 31.
In today's video, I will be looking at the major indices, plus several stocks that are popping up on my radar screen today. These stocks include Apple Inc. (APPLE:AAPL), Alibaba Group Holding Limited (NYSE:BABA) and Facebook Inc. (NASDAQ:FB).
Did you take advantage of Apple's new 52 week high with our 52-week high on a Friday rule? It looks to be heading higher today.
As always, we welcome your comments below on what videos so you would like to see in order for us to provide you with the best type of information that you would like to see. If you have questions about the markets, let us know what they are in your comments.
Every success with MarketClub, Adam Hewison
Overnight actions by the Bank of Japan jump-started the equity markets to seven-year highs in that country, plunging the Japanese yen to its lowest levels since 2008.
The Bank of Japan's big market-moving announcement was that they will triple purchases of exchange-traded funds and real-estate investment trusts. This was clearly a big surprise to all the markets and it sent a big message to the currency markets. This will affect all the other Asian countries as they too will be forced to compete against a cheaper Japanese Yen. Can you say that the currency wars are just starting?
The move by The Bank of Japan (BOJ) was all that was needed to send gold and crude oil prices crashing to the downside.
In today's video, I'll be looking at the U.S. Dollar VS the Japanese Yen (FOREX:USDJPY), gold (FOREX:XAUUSDO) prices, which gave a major sell signal today and crude oil (NYMEX:CL.Z14.E) prices, as they continue their downward spiral.
Today, I'm going to look at three of the biggest portfolio managers in the world and what they're holding in their portfolios. Each of these three billionaire investors have over half of their portfolios in just three stocks.
Everyone it seems has heard of Warren Buffett, the legendary investor from Omaha. I'll be looking at Mr. Buffett's Berkshire Hathaway holdings and his top three stocks and comparing them with the Trade Triangle signals.